EyeBraEyeBrain launches New Medical Device, the EyeBrain T2in launches New Medical Device, the EyeBrain T2
In today’s world of pharma news this might be trailblazing information for all. EyeBrain, cinch develops markers of cerebral function for neurological and psychiatric conditions, has successfully launched a new medical device, the EyeBrain T2. This innovative device would be utilized during examinations of ocular motricity, the motor system controlling eye movements.
The major feature of this new oculometer would expediently record head movement also. It is reported that EyeBrain T2 is far more potent and sensitive than its predecessor, the Mobile EBT (Mobile EyeBrain Tracker). By successfully recording both eye movements and head movements, it is therefore possible to analyze the patient’s gaze during proper examination.
This cogent technological innovation not only permits for more precise measurements, but it would professionally enable additional examinations for persuasive neurologists. These successful examinations are expedient since they offer new markers of cerebral function, permitting neurologists to refine their diagnoses. It is also able to track the development of neurological and psychiatric condition in their patients. The EyeBrain T2 device is facile for practitioners to work with ameliorated ergonomic design. It is also lighter and comfortable than its predecessor. In addition its potent software is reviewed regularly as regarded to be practitioner-friendly.